Bag This Bargain Even Cheaper Than Chief Financial Officer Robb Did
May 09, 2017 at 10:02 AM EDT
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on May 4, Corcept Therapeutics Inc's Chief Financial Officer, Gary Charles Robb, invested $54,588.24 into 5,600 shares of CORT, for a cost per share of $9.75..